Molecular segmentation of luminal breast: Reality in 2015?

详细信息    查看全文

• 作者：Zhi Ling Teo ; Sherene Loi ; ^{sherene.loi@petermac.org" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Breast cancer ; Sequencing ; Biomarkers ; Prognosis ; Genetic alterations
• 刊名：The Breast
• 出版年：2015
• 出版时间：1 November 2015
• 年：2015
• 卷：24
• 期：supp_S2
• 页码：S41-S43
• 全文大小：216 K

文摘

With the advent of next generation sequencing, we are beginning to get a clearer picture of the landscape of genetic alterations in primary breast cancer. One of the key findings has been the heterogeneity of mutational profiles, with no two primary breast tumors being alike. How these genetic alterations will help us manage patients is currently unclear. Studies are ongoing to determine which genetic alterations will signify “oncogenic addiction” and which ones will determine resistance and relapse to current standard therapies.